About Advaxis

Developing the Next Generation of Cancer Immunotherapy

Advaxis is a clinical stage biotechnology company.

Learn more

Clinical Pipeline

Clinical trials for the treatment of HPV-associated cancers

Axalimogene filolisbac (ADXS-HPV), Advaxis’ lead drug candidate is in clinical trials for HPV-associated cancers.